Literature DB >> 32781311

High-dose adolescent nicotine exposure permits spontaneous nicotine self-administration in adult male rats.

Briana Renda1, Allyson K Andrade1, Jude A Frie2, Cassandra L Sgarbossa3, Jennifer E Murray4, Jibran Y Khokhar2.   

Abstract

INTRODUCTION: While cigarette smoking rates have been steadily decreasing over the past decade, there has been a dramatic increase in nicotine use via e-cigarettes, especially during adolescence. Adolescent e-cigarette use is associated with a greater risk of future cigarette smoking, and increased rates of cigarette smoking in individuals who may have otherwise never tried cigarettes. In humans and rodents, early initiation of nicotine use has been associated with greater consumption, dependence, and persistent nicotine use. The present study sought to investigate the long-lasting effect of daily high-dose nicotine exposure during adolescence on nicotine consumption in adulthood.
METHOD: Male Sprague-Dawley rats were exposed daily to nicotine (1.0 mg/kg, subcutaneous), or vehicle (1 mL/kg saline, subcutaneous) during adolescence (post-natal day [P] 28-41). Adult nicotine self-administration (0.02 mg/kg/infusion, intravenous) was assessed beginning on P75 on fixed-ratio 1 (FR1), fixed-interval 1 min (FI1), and progressive ratio (PR) schedules of reinforcement.
RESULTS: Adolescent nicotine pre-exposure did not affect adult nicotine self-administration on the simple FR1 schedule, however increased intake and responding for nicotine was observed when a short delay was implemented on an FI1 schedule of reinforcement.
CONCLUSIONS: Adolescence is a critical period when the brain is especially vulnerable to the effects of nicotine. Nicotine exposure in adolescence enhances susceptibility to increased nicotine intake in adulthood on a reinforcement schedule more reflective of human nicotine intake patterns, and this effect can extend into adulthood even after termination of nicotine exposure during adolescence.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Adolescent; Nicotine; Self-administration; Smoking; Vaping

Year:  2020        PMID: 32781311      PMCID: PMC7502504          DOI: 10.1016/j.drugalcdep.2020.108215

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

Review 1.  The adolescent brain and age-related behavioral manifestations.

Authors:  L P Spear
Journal:  Neurosci Biobehav Rev       Date:  2000-06       Impact factor: 8.989

2.  Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats.

Authors:  Walter Adriani; Sabine Spijker; Véronique Deroche-Gamonet; Giovanni Laviola; Michel Le Moal; August B Smit; Pier Vincenzo Piazza
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

3.  Nicotine self-administration in rats.

Authors:  E C Donny; A R Caggiula; S Knopf; C Brown
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Nicotine competes with a visual stimulus for control of conditioned responding.

Authors:  Jennifer E Murray; Nicole R Wells; Rick A Bevins
Journal:  Addict Biol       Date:  2011-01       Impact factor: 4.280

Review 5.  Adolescent neurodevelopment and substance use: Receptor expression and behavioral consequences.

Authors:  Hayley H A Thorpe; Shahnaza Hamidullah; Bryan W Jenkins; Jibran Y Khokhar
Journal:  Pharmacol Ther       Date:  2019-11-07       Impact factor: 12.310

6.  Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.

Authors:  Laura E O'Dell; Oscar V Torres; Luis A Natividad; Hugo A Tejeda
Journal:  Neurotoxicol Teratol       Date:  2006-11-14       Impact factor: 3.763

7.  Exclusive e-cigarette use predicts cigarette initiation among college students.

Authors:  Alexandra Loukas; C Nathan Marti; Maria Cooper; Keryn E Pasch; Cheryl L Perry
Journal:  Addict Behav       Date:  2017-08-31       Impact factor: 3.913

8.  Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline.

Authors:  Rachel L Schassburger; Melissa E Levin; Matthew T Weaver; Matthew I Palmatier; Anthony R Caggiula; Eric C Donny; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2014-09-12       Impact factor: 4.530

9.  Age differences in the spontaneous acquisition of nicotine self-administration in male Wistar and Long-Evans rats.

Authors:  Megan J Shram; Zhaoxia Li; Anh D Lê
Journal:  Psychopharmacology (Berl)       Date:  2007-11-27       Impact factor: 4.530

Review 10.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

View more
  2 in total

1.  Adolescent nicotine and footshock exposure augments adult nicotine self-administration and drug-seeking without affecting baseline anxiety-like behaviour or stress responsivity in male rats.

Authors:  Briana Renda; Allyson K Andrade; Adiia P S Stone; Rita El Azali; Michael Sharivker; Jibran Y Khokhar; Monica Antenos; Jennifer E Murray
Journal:  Psychopharmacology (Berl)       Date:  2021-03-01       Impact factor: 4.415

2.  Adolescent nicotine treatment causes robust locomotor sensitization during adolescence but impedes the spontaneous acquisition of nicotine intake in adult female Wistar rats.

Authors:  Ranjithkumar Chellian; Azin Behnood-Rod; Ryann Wilson; Marcelo Febo; Adriaan W Bruijnzeel
Journal:  Pharmacol Biochem Behav       Date:  2021-06-28       Impact factor: 3.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.